Open Access

Table 2

Leukocyte concentration and composition in whole blood (WB), LP-PRP, and APS.

PRPs and Blood
components
Healthy volunteers (HV)
Knee osteoarthritis (KOA)
Leukocyte
concentration
(×103/ml)
Cell counts (×103/ml) and composition (%)
Leukocyte
concentration
(×103/ml)
Cell counts (×103 /ml) and composition (%)
Lymphocyte Monocyte Neutrophil Lymphocyte Monocyte Neutrophil
Whole blood 4.3 ± 1.1 1.4 ± 0.3
(33.3 ± 8.4)
0.2 ± 0.09
(5.9 ± 2.0)
2.7 ± 1.1
(60.7 ± 9.0)
5.9 ± 1.0 1.7 ± 0.3
(29.2 ± 4.7)
0.3 ± 0.1
(6.5 ± 2.5)
3.8 ± 0.8
(64.2 ± 4.1)
LP-PRP 1.9 ± 0.8 1.7 ± 0.7
(89.7 ± 3.0)
0.1 ± 0.06
(5.4 ± 2.8)
0.08 ± 0.09
(3.7 ± 2.9)
2.4 ± 1.1 2.3 ± 0.8
(84.8 ± 5.4)
0.2 ± 0.1
(7.5 ± 6.5)
0.2 ± 0.2
(7.5 ± 4.7)
APS 44.1 ± 7.5 20.6 ± 3.2
(47.9 ± 10.7)
5.0 ± 3.2
(11.8 ± 8.0)
18.4 ± 9.4
(40.1 ± 14.8)
26.6 ± 10.5 13.1 ± 3.8
(52.1 ± 15.3)
2.4 ± 1.1
(9.2 ± 2.7)
11.1 ± 7.0
(38.5 ± 16.1)

Data are presented as the mean ± SD. LP-PRP, leukocyte-poor platelet-rich plasma; APS, autologous protein solution.